TY - JOUR
T1 - blaOXA−51-Negative Acinetobacter calcoaceticus–baumannii Complex as a Cause of Human Infection in Peru
AU - Oporto-Llerena, Rosario
AU - Huerto-Huánuco, Rosario
AU - Quispe-Hualpa, Yaneth
AU - Palomino-Kobayashi, Luciano A.
AU - Soza, Gabriela
AU - Rojas-Jaimes, Jesús
AU - Gonzales, Patricia
AU - Pollack, Luis
AU - Gomez, Andrea C.
AU - Salvador-Luján, Gina
AU - Cuaresma, Edwin
AU - Luque, Nestor
AU - Casapia, Martín
AU - Arteaga-Livias, Kovy
AU - Sáenz, Yolanda
AU - Pons, Maria J.
AU - Ruiz, Joaquim
N1 - Publisher Copyright:
Copyright © 2025 Rosario Oporto-Llerena et al. Journal of Tropical Medicine published by John Wiley & Sons Ltd.
PY - 2025
Y1 - 2025
N2 - Background: Common identification techniques do not differentiate among members of the Acinetobacter calcoaceticus–baumannii (ACB) complex, and the presence of non-baumannii Acinetobacter is often misinterpreted. The blaOXA−51 gene is located within the chromosome of Acinetobacter baumannii. Despite its plasmid dissemination to other members of the genus, it may be considered in initial species screening. Thus, this study aimed to determine the presence of blaOXA−51-negative Acinetobacter spp. as a cause of infection in Peru. Methods: Two hundred ninety-eight ACB complex isolates from different regions of Peru were isolated between January 2018 and March 2024. Of these, 272 and 25 were confirmed as hospital-acquired and community infections, respectively. The presence of blaOXA−51 was determined by polymerase chain reaction, and the susceptibility levels to 12 antimicrobial agents were determined. Results: The results showed that 38 (12.7%) isolates were blaOXA−51-negative. These isolates were frequent among community infections (13/25, p < 0.0001), often causing urine infections. They showed significantly lower levels of resistance to almost all antimicrobial agents tested, and most of them were recovered from regions outside metropolitan Lima. Conclusion: A relevant number of infections by non-baumannii Acinetobacter species in Peru is suggested, highlighting the need for systematic identification of these species in the country.
AB - Background: Common identification techniques do not differentiate among members of the Acinetobacter calcoaceticus–baumannii (ACB) complex, and the presence of non-baumannii Acinetobacter is often misinterpreted. The blaOXA−51 gene is located within the chromosome of Acinetobacter baumannii. Despite its plasmid dissemination to other members of the genus, it may be considered in initial species screening. Thus, this study aimed to determine the presence of blaOXA−51-negative Acinetobacter spp. as a cause of infection in Peru. Methods: Two hundred ninety-eight ACB complex isolates from different regions of Peru were isolated between January 2018 and March 2024. Of these, 272 and 25 were confirmed as hospital-acquired and community infections, respectively. The presence of blaOXA−51 was determined by polymerase chain reaction, and the susceptibility levels to 12 antimicrobial agents were determined. Results: The results showed that 38 (12.7%) isolates were blaOXA−51-negative. These isolates were frequent among community infections (13/25, p < 0.0001), often causing urine infections. They showed significantly lower levels of resistance to almost all antimicrobial agents tested, and most of them were recovered from regions outside metropolitan Lima. Conclusion: A relevant number of infections by non-baumannii Acinetobacter species in Peru is suggested, highlighting the need for systematic identification of these species in the country.
KW - Acinetobacter spp.
KW - OXA-51
KW - antibiotic resistance
KW - community-acquired infection
KW - hospital-acquired infection
UR - https://www.scopus.com/pages/publications/105023409695
U2 - 10.1155/jotm/8851906
DO - 10.1155/jotm/8851906
M3 - Article
AN - SCOPUS:105023409695
SN - 1687-9686
VL - 2025
JO - Journal of Tropical Medicine
JF - Journal of Tropical Medicine
IS - 1
M1 - 8851906
ER -